nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorprothixene—ABCB1—Mycophenolate mofetil—psoriasis	0.164	0.168	CbGbCtD
Chlorprothixene—ABCB1—Betamethasone—psoriasis	0.14	0.144	CbGbCtD
Chlorprothixene—ABCB1—Prednisolone—psoriasis	0.138	0.142	CbGbCtD
Chlorprothixene—ABCB1—Hydrocortisone—psoriasis	0.131	0.135	CbGbCtD
Chlorprothixene—ABCB1—Prednisone—psoriasis	0.131	0.134	CbGbCtD
Chlorprothixene—ABCB1—Cyclosporine—psoriasis	0.124	0.127	CbGbCtD
Chlorprothixene—ABCB1—Dexamethasone—psoriasis	0.0817	0.0837	CbGbCtD
Chlorprothixene—ABCB1—Methotrexate—psoriasis	0.0656	0.0672	CbGbCtD
Chlorprothixene—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.32e-05	0.000963	CbGpPWpGaD
Chlorprothixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.31e-05	0.00096	CbGpPWpGaD
Chlorprothixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.3e-05	0.000957	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—CCL20—psoriasis	2.29e-05	0.00095	CbGpPWpGaD
Chlorprothixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	2.28e-05	0.000948	CbGpPWpGaD
Chlorprothixene—HTR2A—SIDS Susceptibility Pathways—IL6—psoriasis	2.28e-05	0.000947	CbGpPWpGaD
Chlorprothixene—CHRM2—SIDS Susceptibility Pathways—IL6—psoriasis	2.24e-05	0.000929	CbGpPWpGaD
Chlorprothixene—DRD2—Circadian rythm related genes—TP53—psoriasis	2.06e-05	0.000858	CbGpPWpGaD
Chlorprothixene—HTR2C—GPCR ligand binding—CXCL8—psoriasis	2.04e-05	0.000847	CbGpPWpGaD
Chlorprothixene—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	2.03e-05	0.000843	CbGpPWpGaD
Chlorprothixene—CHRM1—Circadian rythm related genes—TP53—psoriasis	2.02e-05	0.00084	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—CCL20—psoriasis	2.02e-05	0.000839	CbGpPWpGaD
Chlorprothixene—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.02e-05	0.000838	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—CARM1—psoriasis	2e-05	0.000832	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—CCL20—psoriasis	1.99e-05	0.000825	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—CCL20—psoriasis	1.98e-05	0.000824	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—CCL20—psoriasis	1.97e-05	0.000821	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—CCL20—psoriasis	1.97e-05	0.000818	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—CCL20—psoriasis	1.95e-05	0.00081	CbGpPWpGaD
Chlorprothixene—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.94e-05	0.000807	CbGpPWpGaD
Chlorprothixene—DRD2—Circadian rythm related genes—IL6—psoriasis	1.89e-05	0.000785	CbGpPWpGaD
Chlorprothixene—CHRM1—Circadian rythm related genes—IL6—psoriasis	1.85e-05	0.000769	CbGpPWpGaD
Chlorprothixene—DRD2—GPCR ligand binding—CXCL8—psoriasis	1.8e-05	0.000747	CbGpPWpGaD
Chlorprothixene—HTR2A—GPCR ligand binding—CXCL8—psoriasis	1.77e-05	0.000735	CbGpPWpGaD
Chlorprothixene—HRH1—GPCR ligand binding—CXCL8—psoriasis	1.76e-05	0.000734	CbGpPWpGaD
Chlorprothixene—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.76e-05	0.000732	CbGpPWpGaD
Chlorprothixene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.76e-05	0.000732	CbGpPWpGaD
Chlorprothixene—CHRM1—GPCR ligand binding—CXCL8—psoriasis	1.76e-05	0.000731	CbGpPWpGaD
Chlorprothixene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.76e-05	0.000731	CbGpPWpGaD
Chlorprothixene—CHRM3—GPCR ligand binding—CXCL8—psoriasis	1.75e-05	0.000729	CbGpPWpGaD
Chlorprothixene—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.75e-05	0.000728	CbGpPWpGaD
Chlorprothixene—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.75e-05	0.000726	CbGpPWpGaD
Chlorprothixene—CHRM2—GPCR ligand binding—CXCL8—psoriasis	1.74e-05	0.000722	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—SOCS1—psoriasis	1.71e-05	0.000711	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling by GPCR—TYK2—psoriasis	1.63e-05	0.000678	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—SOCS1—psoriasis	1.61e-05	0.00067	CbGpPWpGaD
Chlorprothixene—HTR6—GPCR downstream signaling—CXCL8—psoriasis	1.56e-05	0.00065	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—SOCS1—psoriasis	1.56e-05	0.000649	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—SOCS1—psoriasis	1.54e-05	0.000642	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling by GPCR—TYK2—psoriasis	1.54e-05	0.000639	CbGpPWpGaD
Chlorprothixene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.51e-05	0.000628	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling by GPCR—TYK2—psoriasis	1.49e-05	0.000618	CbGpPWpGaD
Chlorprothixene—CHRM4—GPCR downstream signaling—CXCL8—psoriasis	1.47e-05	0.000613	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling by GPCR—TYK2—psoriasis	1.47e-05	0.000612	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—SOCS1—psoriasis	1.47e-05	0.000612	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—SOCS1—psoriasis	1.45e-05	0.000604	CbGpPWpGaD
Chlorprothixene—HTR2B—GPCR downstream signaling—CXCL8—psoriasis	1.43e-05	0.000593	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling by GPCR—CXCL8—psoriasis	1.42e-05	0.00059	CbGpPWpGaD
Chlorprothixene—CHRM5—GPCR downstream signaling—CXCL8—psoriasis	1.41e-05	0.000587	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling by GPCR—TYK2—psoriasis	1.4e-05	0.000583	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling by GPCR—TYK2—psoriasis	1.38e-05	0.000576	CbGpPWpGaD
Chlorprothixene—DRD1—GPCR downstream signaling—CXCL8—psoriasis	1.35e-05	0.000559	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling by GPCR—CXCL8—psoriasis	1.34e-05	0.000557	CbGpPWpGaD
Chlorprothixene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.33e-05	0.000553	CbGpPWpGaD
Chlorprothixene—DRD3—GPCR downstream signaling—CXCL8—psoriasis	1.33e-05	0.000552	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling by GPCR—CXCL8—psoriasis	1.3e-05	0.000539	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling by GPCR—CXCL8—psoriasis	1.28e-05	0.000533	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—CARM1—psoriasis	1.27e-05	0.000528	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—APOE—psoriasis	1.26e-05	0.000524	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—LEP—psoriasis	1.26e-05	0.000524	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—SOCS1—psoriasis	1.26e-05	0.000523	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—CAT—psoriasis	1.23e-05	0.000512	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling by GPCR—CXCL8—psoriasis	1.22e-05	0.000508	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling by GPCR—CXCL8—psoriasis	1.21e-05	0.000501	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling by GPCR—TYK2—psoriasis	1.2e-05	0.000499	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—LEP—psoriasis	1.19e-05	0.000495	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—APOE—psoriasis	1.19e-05	0.000495	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—NFKBIA—psoriasis	1.18e-05	0.000489	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—APOE—psoriasis	1.15e-05	0.000479	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—LEP—psoriasis	1.15e-05	0.000479	CbGpPWpGaD
Chlorprothixene—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	1.15e-05	0.000478	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—LEP—psoriasis	1.14e-05	0.000474	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—APOE—psoriasis	1.14e-05	0.000474	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—SOCS1—psoriasis	1.11e-05	0.000462	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—NFKBIA—psoriasis	1.11e-05	0.000461	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—SOCS1—psoriasis	1.09e-05	0.000454	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—SOCS1—psoriasis	1.09e-05	0.000453	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—SOCS1—psoriasis	1.09e-05	0.000452	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—LEP—psoriasis	1.09e-05	0.000451	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—APOE—psoriasis	1.09e-05	0.000451	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—SOCS1—psoriasis	1.08e-05	0.000451	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—SOCS1—psoriasis	1.07e-05	0.000446	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—NFKBIA—psoriasis	1.07e-05	0.000446	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—APOE—psoriasis	1.07e-05	0.000445	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—LEP—psoriasis	1.07e-05	0.000445	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—NFKBIA—psoriasis	1.06e-05	0.000441	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling by GPCR—TYK2—psoriasis	1.06e-05	0.00044	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling by GPCR—CXCL8—psoriasis	1.04e-05	0.000434	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling by GPCR—TYK2—psoriasis	1.04e-05	0.000433	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling by GPCR—TYK2—psoriasis	1.04e-05	0.000432	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling by GPCR—TYK2—psoriasis	1.04e-05	0.000431	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling by GPCR—TYK2—psoriasis	1.03e-05	0.00043	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling by GPCR—TYK2—psoriasis	1.02e-05	0.000425	CbGpPWpGaD
Chlorprothixene—DRD2—GPCR downstream signaling—CXCL8—psoriasis	1.02e-05	0.000422	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—NFKBIA—psoriasis	1.01e-05	0.000421	CbGpPWpGaD
Chlorprothixene—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	9.99e-06	0.000415	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—NFKBIA—psoriasis	9.98e-06	0.000415	CbGpPWpGaD
Chlorprothixene—HRH1—GPCR downstream signaling—CXCL8—psoriasis	9.97e-06	0.000415	CbGpPWpGaD
Chlorprothixene—CHRM1—GPCR downstream signaling—CXCL8—psoriasis	9.94e-06	0.000413	CbGpPWpGaD
Chlorprothixene—CHRM3—GPCR downstream signaling—CXCL8—psoriasis	9.91e-06	0.000412	CbGpPWpGaD
Chlorprothixene—CHRM2—GPCR downstream signaling—CXCL8—psoriasis	9.81e-06	0.000408	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—TYK2—psoriasis	9.63e-06	0.0004	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—APOE—psoriasis	9.57e-06	0.000398	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—LEP—psoriasis	9.29e-06	0.000386	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—APOE—psoriasis	9.29e-06	0.000386	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling by GPCR—CXCL8—psoriasis	9.22e-06	0.000383	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—TYK2—psoriasis	9.08e-06	0.000378	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling by GPCR—CXCL8—psoriasis	9.07e-06	0.000377	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling by GPCR—CXCL8—psoriasis	9.05e-06	0.000376	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling by GPCR—CXCL8—psoriasis	9.03e-06	0.000375	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling by GPCR—CXCL8—psoriasis	9e-06	0.000374	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling by GPCR—CXCL8—psoriasis	8.91e-06	0.00037	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—TYK2—psoriasis	8.79e-06	0.000365	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—TYK2—psoriasis	8.7e-06	0.000362	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—NFKBIA—psoriasis	8.66e-06	0.00036	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—CXCL8—psoriasis	8.38e-06	0.000349	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—PPARG—psoriasis	8.33e-06	0.000346	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—TYK2—psoriasis	8.29e-06	0.000345	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—LEP—psoriasis	8.2e-06	0.000341	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—APOE—psoriasis	8.2e-06	0.000341	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—TYK2—psoriasis	8.18e-06	0.00034	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—LEP—psoriasis	8.07e-06	0.000335	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—APOE—psoriasis	8.07e-06	0.000335	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—APOE—psoriasis	8.05e-06	0.000335	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—LEP—psoriasis	8.05e-06	0.000335	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—APOE—psoriasis	8.02e-06	0.000334	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—LEP—psoriasis	8.02e-06	0.000334	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—LEP—psoriasis	8e-06	0.000333	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—APOE—psoriasis	8e-06	0.000333	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling by GPCR—IL6—psoriasis	7.97e-06	0.000331	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—APOE—psoriasis	7.92e-06	0.000329	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—LEP—psoriasis	7.92e-06	0.000329	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—CXCL8—psoriasis	7.91e-06	0.000329	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—CAT—psoriasis	7.81e-06	0.000325	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—JUN—psoriasis	7.79e-06	0.000324	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—CXCL8—psoriasis	7.65e-06	0.000318	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—NFKBIA—psoriasis	7.64e-06	0.000318	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—CXCL8—psoriasis	7.57e-06	0.000315	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling by GPCR—IL6—psoriasis	7.52e-06	0.000313	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—NFKBIA—psoriasis	7.52e-06	0.000313	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—NFKB1—psoriasis	7.5e-06	0.000312	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—NFKBIA—psoriasis	7.5e-06	0.000312	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—NFKBIA—psoriasis	7.48e-06	0.000311	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—NFKBIA—psoriasis	7.45e-06	0.00031	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—NFKBIA—psoriasis	7.38e-06	0.000307	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—JUN—psoriasis	7.35e-06	0.000306	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling by GPCR—IL6—psoriasis	7.28e-06	0.000302	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—CXCL8—psoriasis	7.22e-06	0.0003	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling by GPCR—IL6—psoriasis	7.2e-06	0.000299	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—CXCL8—psoriasis	7.12e-06	0.000296	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—JUN—psoriasis	7.11e-06	0.000296	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—TYK2—psoriasis	7.09e-06	0.000295	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—NFKB1—psoriasis	7.08e-06	0.000294	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—JUN—psoriasis	7.04e-06	0.000293	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling by GPCR—IL6—psoriasis	6.86e-06	0.000285	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—NFKB1—psoriasis	6.85e-06	0.000285	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—VEGFA—psoriasis	6.81e-06	0.000283	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—NFKB1—psoriasis	6.78e-06	0.000282	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling by GPCR—IL6—psoriasis	6.77e-06	0.000281	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—STAT3—psoriasis	6.74e-06	0.00028	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—JUN—psoriasis	6.71e-06	0.000279	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—JUN—psoriasis	6.62e-06	0.000275	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—NFKB1—psoriasis	6.46e-06	0.000268	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—VEGFA—psoriasis	6.42e-06	0.000267	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—NFKB1—psoriasis	6.37e-06	0.000265	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—STAT3—psoriasis	6.36e-06	0.000264	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—TYK2—psoriasis	6.26e-06	0.00026	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—VEGFA—psoriasis	6.21e-06	0.000258	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—CXCL8—psoriasis	6.17e-06	0.000257	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—TYK2—psoriasis	6.16e-06	0.000256	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—STAT3—psoriasis	6.15e-06	0.000256	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—VEGFA—psoriasis	6.15e-06	0.000256	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—TYK2—psoriasis	6.14e-06	0.000255	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—TYK2—psoriasis	6.12e-06	0.000255	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—TYK2—psoriasis	6.1e-06	0.000254	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—STAT3—psoriasis	6.09e-06	0.000253	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—APOE—psoriasis	6.07e-06	0.000252	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—TYK2—psoriasis	6.05e-06	0.000251	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling by GPCR—IL6—psoriasis	5.87e-06	0.000244	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—VEGFA—psoriasis	5.86e-06	0.000244	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—STAT3—psoriasis	5.8e-06	0.000241	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—VEGFA—psoriasis	5.78e-06	0.00024	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—JUN—psoriasis	5.74e-06	0.000239	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—STAT3—psoriasis	5.73e-06	0.000238	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—NFKB1—psoriasis	5.52e-06	0.00023	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—CXCL8—psoriasis	5.45e-06	0.000227	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—CXCL8—psoriasis	5.36e-06	0.000223	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—CXCL8—psoriasis	5.35e-06	0.000222	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—CXCL8—psoriasis	5.33e-06	0.000222	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—CXCL8—psoriasis	5.31e-06	0.000221	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—PPARG—psoriasis	5.29e-06	0.00022	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—CXCL8—psoriasis	5.26e-06	0.000219	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling by GPCR—IL6—psoriasis	5.18e-06	0.000215	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—TP53—psoriasis	5.14e-06	0.000214	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling by GPCR—IL6—psoriasis	5.1e-06	0.000212	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling by GPCR—IL6—psoriasis	5.09e-06	0.000211	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling by GPCR—IL6—psoriasis	5.07e-06	0.000211	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—JUN—psoriasis	5.06e-06	0.000211	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling by GPCR—IL6—psoriasis	5.05e-06	0.00021	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—VEGFA—psoriasis	5.01e-06	0.000208	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling by GPCR—IL6—psoriasis	5e-06	0.000208	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—JUN—psoriasis	4.98e-06	0.000207	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—JUN—psoriasis	4.97e-06	0.000207	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—STAT3—psoriasis	4.96e-06	0.000206	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—JUN—psoriasis	4.96e-06	0.000206	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—JUN—psoriasis	4.94e-06	0.000205	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—JUN—psoriasis	4.89e-06	0.000203	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—NFKB1—psoriasis	4.88e-06	0.000203	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—TP53—psoriasis	4.85e-06	0.000202	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—NFKB1—psoriasis	4.8e-06	0.000199	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—NFKB1—psoriasis	4.79e-06	0.000199	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—NFKB1—psoriasis	4.77e-06	0.000198	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—NFKB1—psoriasis	4.76e-06	0.000198	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—NFKB1—psoriasis	4.71e-06	0.000196	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—IL6—psoriasis	4.71e-06	0.000196	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—TP53—psoriasis	4.7e-06	0.000195	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—TP53—psoriasis	4.65e-06	0.000193	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—IL6—psoriasis	4.44e-06	0.000185	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—TP53—psoriasis	4.43e-06	0.000184	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—VEGFA—psoriasis	4.42e-06	0.000184	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—STAT3—psoriasis	4.38e-06	0.000182	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—TP53—psoriasis	4.37e-06	0.000182	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—VEGFA—psoriasis	4.35e-06	0.000181	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—VEGFA—psoriasis	4.34e-06	0.000181	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—VEGFA—psoriasis	4.33e-06	0.00018	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—VEGFA—psoriasis	4.32e-06	0.000179	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—STAT3—psoriasis	4.31e-06	0.000179	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—STAT3—psoriasis	4.3e-06	0.000179	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—IL6—psoriasis	4.3e-06	0.000179	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—STAT3—psoriasis	4.29e-06	0.000178	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—VEGFA—psoriasis	4.27e-06	0.000178	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—STAT3—psoriasis	4.27e-06	0.000178	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—IL6—psoriasis	4.25e-06	0.000177	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—STAT3—psoriasis	4.23e-06	0.000176	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—IL6—psoriasis	4.05e-06	0.000169	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—IL6—psoriasis	4e-06	0.000166	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—TP53—psoriasis	3.79e-06	0.000158	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—IL6—psoriasis	3.47e-06	0.000144	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—TP53—psoriasis	3.34e-06	0.000139	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—TP53—psoriasis	3.29e-06	0.000137	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—TP53—psoriasis	3.28e-06	0.000136	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—TP53—psoriasis	3.27e-06	0.000136	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—TP53—psoriasis	3.26e-06	0.000136	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—TP53—psoriasis	3.23e-06	0.000134	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—IL6—psoriasis	3.06e-06	0.000127	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—IL6—psoriasis	3.01e-06	0.000125	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—IL6—psoriasis	3e-06	0.000125	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—IL6—psoriasis	3e-06	0.000125	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—IL6—psoriasis	2.99e-06	0.000124	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—IL6—psoriasis	2.96e-06	0.000123	CbGpPWpGaD
